Literature DB >> 5660117

Separation of porphobilinogen deaminase and uroporphyrinogen 3 cosynthetase from human erythrocytes.

E Stevens, R B Frydman, B Frydman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5660117     DOI： 10.1016/0304-4165(68)90314-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  6 in total

1.  Congenital erythropoietic porphyria and congenital adrenal hyperplasia with evidence for hepatic delta-5 alpha-reductase deficiency.

Authors:  J A Miller; G M Levene
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

2.  Studies on the porphobilinogen deaminase-uroporphyrinogen cosynthetase system of cultured soya-bean cells.

Authors:  E B Llambías; A M Battle
Journal:  Biochem J       Date:  1971-01       Impact factor: 3.857

3.  Uroporphyrinogen I synthase from human erythrocytes: separation, purification, and properties of isoenzymes.

Authors:  K Miyagi; M Kaneshima; J Kawakami; F Nakada; Z J Petryka; C J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.

Authors:  P M Anderson; R M Reddy; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria.

Authors:  G Romeo; E Y Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

Review 6.  Solutions in microbiome engineering: prioritizing barriers to organism establishment.

Authors:  Michaeline B N Albright; Stilianos Louca; Daniel E Winkler; Kelli L Feeser; Sarah-Jane Haig; Katrine L Whiteson; Joanne B Emerson; John Dunbar
Journal:  ISME J       Date:  2021-08-21       Impact factor: 10.302
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.